Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pipeline Watch: Phase III Starts With Simvastatin, AR101 And Brexanolone

May 12 2017

• By John Davis

Pipeline Watch regular column feature image — Pipeline Watch

Related Companies

Chugai Pharmaceutical Co., Ltd.

Roche Holding AG

Array BioPharma, Inc.

Pierre Fabre

Evoke Pharma, Inc.

Synergy Pharmaceuticals, Inc.

EyePoint Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Ocular Therapeutix, Inc.

Agile Therapeutics, Inc.

RedHill Biopharma Ltd.

AstraZeneca PLC

Sanofi

Lexicon Pharmaceuticals, Inc.

AstraZeneca PLC

Roche Holding AG

Teva Pharmaceutical Industries Ltd.

Active Biotech AB

Altamira Therapeutics Ltd.

Societal CDMO, Inc.

GSK plc

Innoviva, Inc.

Takeda Pharmaceutical Co. Ltd.

Aimmune Therapeutics, Inc.

Sage Therapeutics, Inc.

Ligand Pharmaceuticals, Inc.

Daiichi Sankyo Co., Ltd.

Protalix BioTherapeutics, Inc.

OncoMed Pharmaceuticals, Inc.

AbbVie Inc.

Rhythm Pharmaceuticals, Inc.

Acceleron Pharma, Inc.

AbbVie Inc.

Sage Therapeutics, Inc.

Myovant Sciences Ltd.

Takeda Pharmaceutical Co. Ltd.

EA Pharma Co., Ltd.

Mereo BioPharma Group plc

PureTech Health plc

AiCuris Anti-infective Cures GmbH

GSK plc

Ionis Pharmaceuticals, Inc.

Kite Pharma, Inc.

Quest PharmaTech Inc.

Boehringer Ingelheim GmbH

AbbVie Inc.

Affibody AB

Sage Therapeutics, Inc.

Genfit SA

Additional Topics

Approvals Research & Development Pipeline Watch BioPharmaceutical

More from Pipeline Watch

More from R&D

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window